22nd Century Group, Inc.
(NASDAQ : XXII)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
REGNRegeneron Pharmaceuticals, Inc. -0.25%733.322.6%$777.63m
MRNAModerna, Inc. 3.62%125.370.0%$636.17m
AMGNAmgen, Inc. 1.32%233.491.4%$631.99m
BIIBBiogen, Inc. 1.27%267.651.8%$594.75m
GILDGilead Sciences, Inc. 3.88%64.741.0%$551.24m
VRTXVertex Pharmaceuticals, Inc. 0.72%299.571.9%$429.92m
ILMNIllumina, Inc. 8.19%202.573.2%$381.06m
SNSSSunesis Pharmaceuticals, Inc. 4.59%4.330.7%$302.68m
SAVACassava Sciences, Inc. 1.45%42.100.0%$199.93m
BNTXBioNTech SE 1.98%139.380.0%$117.55m
NVAXNovavax, Inc. 3.60%19.2775.6%$88.82m
PRTAProthena Corp. Plc 1.80%62.9313.8%$85.50m
BMRNBioMarin Pharmaceutical, Inc. 0.21%86.894.2%$85.40m
TECHBio-Techne Corp. 3.19%302.424.5%$81.40m
NRBONeuroBo Pharmaceuticals, Inc. 1.06%13.400.0%$81.11m

Company Profile

22nd Century Group, Inc. is a biotechnology company, which develops disruptive plant-based solutions the for life science, consumer product, and pharmaceutical markets. It focuses on technologies that alter the level of nicotine in tobacco plants and the level of cannabinoids in hemp or cannabis plants through genetic engineering, gene-editing, and modern plant breeding techniques. The company was founded on September 12, 2005 and is headquartered in Buffalo, NY.